A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
Public ClinicalTrials.gov record NCT00877890. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Parallel-Group, Comparator-Controlled, Multicenter Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will compare the effects of commercially manufactured exenatide once weekly and exenatide BID in subjects whose type 2 diabetes is managed with diet and exercise alone or with oral antidiabetic medications. The study will examine glycemic control (as measured by HbA1C), safety, and tolerability.
Study identification
- NCT ID
- NCT00877890
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 254 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Jan 2010 (Actual)
- Last update posted
- Apr 7, 2015
2009 – 2010
United States locations
- U.S. sites
- 41
- U.S. states
- 19
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Mesa | Arizona | — | — |
| Research Site | Peoria | Arizona | — | — |
| Research Site | Artesia | California | — | — |
| Research Site | Concord | California | — | — |
| Research Site | Encino | California | — | — |
| Research Site | Greenbrae | California | — | — |
| Research Site | La Mesa | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | DeLand | Florida | — | — |
| Research Site | Hialeah | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | New Port Richey | Florida | — | — |
| Research Site | Palm Harbor | Florida | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Avon | Indiana | — | — |
| Research Site | Evansville | Indiana | — | — |
| Research Site | Lexington | Kentucky | — | — |
| Research Site | Paducah | Kentucky | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Edina | Minnesota | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | New Hyde Park | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Statesville | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Delaware | Ohio | — | — |
| Research Site | Mentor | Ohio | — | — |
| Research Site | Eugene | Oregon | — | — |
| Research Site | Rapid City | South Dakota | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Burke | Virginia | — | — |
| Research Site | Manassas | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Olympia | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
| Research Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00877890, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2015 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00877890 live on ClinicalTrials.gov.